Axsome Therapeutics, Inc. (AXSM) Revenue History
Axsome Therapeutics, Inc. (AXSM) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | N/A |
| 2017-12-31 | N/A |
| 2018-12-31 | N/A |
| 2019-12-31 | N/A |
| 2020-12-31 | N/A |
| 2021-12-31 | N/A |
| 2022-12-31 | $50.04M |
| 2023-12-31 | $270.60M |
| 2024-12-31 | $385.69M |
| 2025-12-31 | $638.50M |
How AXSM compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| NEO | NeoGenomics Inc. | $727.33M |
| AMPH | Amphastar Pharmaceuticals Inc. | $719.89M |
| RARE | Ultragenyx Pharmaceutical Inc. | $673.00M |
| TGTX | TG Therapeutics Inc. | $616.29M |
| AZTA | Azenta Inc. | $593.82M |
These are five companies in the same sector as AXSM with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Axsome Therapeutics, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("AXSM", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | AXSM | $214.07 | -0.27% | 0.47M |
| 3 | ||||
| 4 | ||||
| 5 |